Literature DB >> 10390588

Value of intravenous cholangiography prior to laparoscopic cholecystectomy.

M Jansen1, S Truong, K H Treutner, J Neuerburg, C Schraven, V Schumpelick.   

Abstract

We performed a retrospective study on 163 patients for evaluation of the benefit of intravenous cholangiography prior to laparoscopic cholecystectomy. Radiographic evaluation of the various areas of the biliary system was classified regarding resolution of anatomic structures: well detailed (excellent), impaired image but reliable interpretation possible (good), insufficient contrast with limited assessment (poor), no reliable judgment possible (insufficient). The common bile duct could be described as "good" in 96.3%, whereas the cystic duct could be described as "good" in only 54.6%. Concrements of the gallbladder were recognized in 72.4%, and common bile duct stones were diagnosed in only two of three patients. A distal junction of the cystic duct was found in nine cases, but there was no influence on the following operative procedure. Only one of two patients with a short cystic duct was identified. We found no improvement after routine use of intravenous cholangiography concerning the evidence of common bile duct stones or the avoidance of lesions of the common bile duct. Hence routine use of intravenous cholangiography prior to laparoscopic cholecystectomy is not justified.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10390588     DOI: 10.1007/pl00012370

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  2 in total

1.  The significance of cystic duct stones encountered during laparoscopic cholecystectomy.

Authors:  S Mahmud; Y Hamza; A H Nassar
Journal:  Surg Endosc       Date:  2001-03-13       Impact factor: 4.584

2.  Accuracy of computed tomographic intravenous cholangiography (CT-IVC) with iotroxate in the detection of choledocholithiasis.

Authors:  Robert N Gibson; Janette M Vincent; Tony Speer; Neil A Collier; Keith Noack
Journal:  Eur Radiol       Date:  2004-12-31       Impact factor: 5.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.